Raikar serves as a principal investigator on multiple clinical trials involving valve replacement, heart failure, and arrhythmia treatment. His research has appeared in peer-reviewed journals and ...
The third-party logistics (3PL) market is experiencing robust growth, fueled by the rapid expansion of e-commerce, ...
Very small clarification, Mohit, we saw the NCLT approval for MakeMyTrip and the redBus merger, which in a way sort of removes any legal or regulatory overhang from a potential India IPO point of view ...
In 2025, the landscape of no-code AI platforms is really starting to mature. It’s becoming easier than ever for folks without ...